A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Adverse reactions; Registrational
- Acronyms GWPCARE7
- Sponsors GW Pharmaceuticals
- 20 Oct 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
- 20 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 17 Mar 2017 Planned End Date changed from 1 Nov 2019 to 1 Sep 2017.